Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma 15 Osteosarcoma 8 Neuroectodermal Tumors, Primitive, Peripheral 3 Liposarcoma 3 Hemangiopericytoma, Malignant 3 Gliosarcoma 3 Glioblastoma 3 Fibrosarcoma 3 Brain Neoplasms 3 Malignant mesenchymal tumor 2 Hemangiosarcoma 2 Glioma 2 Gastrointestinal Stromal Tumors 2 Desmoplastic Small Round Cell Tumor 2 Dermatofibrosarcoma 2 Central Nervous System Neoplasms 2 Astrocytoma 2 Sarcoma, Alveolar Soft Part 1 Rhabdomyosarcoma 1 Ovarian Neoplasms 1 Neurofibrosarcoma 1 Neoplasms 1 Neoplasm Metastasis 1 Leiomyosarcoma 1 Histiocytoma, Malignant Fibrous 1 Chondrosarcoma, Extraskeletal Myxoid 1 Chondrosarcoma 1 Cardiotoxicity 1

Interventions

Doxorubicin 25 Gemcitabine 16 Trabectedin 12 Ifosfamide 12 Radiotherapy 11 Docetaxel 10 Dacarbazine 8 pazopanib 7 Nivolumab 6 Specimen Handling 5 Biopsy 5 liposomal doxorubicin 4 Temozolomide 4 pembrolizumab 3 Sunitinib 3 Sorafenib 3 Radiation 3 Magnetic Resonance Spectroscopy 3 Filgrastim 3 rucaparib 2 pegfilgrastim 2 olaratumab 2 eribulin 2 durvalumab 2 cixutumumab 2 cemiplimab 2 brostallicin 2 belinostat 2 avelumab 2 X-Rays 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Leiomyosarcoma × Neoadjuvant Therapy × Sarcoma × Clear all

NCT04031677 2026-05-22

STRASS2

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Recruiting

Leiomyosarcoma, Liposarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡